Literature DB >> 15005689

Loss of heterozygosity on chromosome 4q32-35 in sporadic basal cell carcinomas: evidence for the involvement of p33ING2/ING1L and SAP30 genes.

Elena Sironi1, Amilcare Cerri, Dario Tomasini, Silvia Maria Sirchia, Giovanni Porta, Franca Rossella, Francesca Romana Grati, Giuseppe Simoni.   

Abstract

BACKGROUND: Studies on basal cell carcinoma (BCC) have demonstrated that patched gene and p53 gene located at 9q22.3 and 17p13 are the main genes responsible for the onset of this tumor. In order to identify a possible involvement of other tumor suppressor genes, we screened 19 cases of BCCs for loss of heterozygosity (LOH).
METHODS: The analysis was performed on tumoral tissue and on corresponding normal tissue by using a panel of 37 polymorphic markers spanning 26 chromosomal regions.
RESULTS: We observed that only four chromosomal regions, 4q32 (30.00%), 4q35 (27.27%), 9q21-22 (28.57%), and 9q22-qter (35.71%), demonstrated a significative LOH (>20%), even if others show a borderline percentage (15-20%) of imbalance (1q32, 3p24, 10p22.1, and 17q21.3).
CONCLUSIONS: Our findings suggest that a new chromosomal region mapping in the long arm of chromosome 4 could be involved in sporadic BCC carcinogenesis. Further analyses indicate that the minimal deleted region in 4q32-35 includes p33ING2/ING1L and SAP30, whose deletion could impair the G1-phase checkpoint control and favor gene silencing, respectively.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15005689     DOI: 10.1111/j.0303-6987.2004.0187.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  11 in total

1.  Frequent deletion of ING2 locus at 4q35.1 associates with advanced tumor stage in head and neck squamous cell carcinoma.

Authors:  Silvia S Borkosky; Mehmet Gunduz; Hitoshi Nagatsuka; Levent Bekir Beder; Esra Gunduz; Mahmoud A L Sheikh Ali; Andrea P Rodriguez; Mehmet Zeynel Cilek; Susumu Tominaga; Noboru Yamanaka; Kenji Shimizu; Noriyuki Nagai
Journal:  J Cancer Res Clin Oncol       Date:  2008-11-08       Impact factor: 4.553

2.  Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.

Authors:  Basavaraj Vastrad; Chanabasayya Vastrad; Ashok Godavarthi; Raghu Chandrashekar
Journal:  Med Oncol       Date:  2017-09-26       Impact factor: 3.064

3.  Deacetylase inhibitors dissociate the histone-targeting ING2 subunit from the Sin3 complex.

Authors:  Karen T Smith; Skylar A Martin-Brown; Laurence Florens; Michael P Washburn; Jerry L Workman
Journal:  Chem Biol       Date:  2010-01-29

Review 4.  ING1 and ING2: multifaceted tumor suppressor genes.

Authors:  Claire Guérillon; Delphine Larrieu; Rémy Pedeux
Journal:  Cell Mol Life Sci       Date:  2013-02-15       Impact factor: 9.261

Review 5.  Inhibitor of growth tumor suppressors in cancer progression.

Authors:  Brad Piche; Gang Li
Journal:  Cell Mol Life Sci       Date:  2010-03-02       Impact factor: 9.261

6.  A novel tumor suppressor gene in basal cell carcinoma: inhibition of growth factor-2.

Authors:  Metin Temel; Arif Turkmen; Recep Dokuyucu; Cengiz Cevik; Serdar Oztuzcu; Beyhan Cengiz; Mehmet Mutaf
Journal:  Tumour Biol       Date:  2015-01-23

7.  Genome-wide transcriptional analysis of the human cell cycle identifies genes differentially regulated in normal and cancer cells.

Authors:  Ziv Bar-Joseph; Zahava Siegfried; Michael Brandeis; Benedikt Brors; Yong Lu; Roland Eils; Brian D Dynlacht; Itamar Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-14       Impact factor: 11.205

8.  Redox-dependent disulfide bond formation in SAP30L corepressor protein: Implications for structure and function.

Authors:  Mikko Laitaoja; Helena Tossavainen; Tero Pihlajamaa; Jarkko Valjakka; Keijo Viiri; Olli Lohi; Perttu Permi; Janne Jänis
Journal:  Protein Sci       Date:  2015-12-10       Impact factor: 6.725

9.  Nuclear ING2 expression is reduced in human cutaneous melanomas.

Authors:  F Lu; D L Dai; M Martinka; V Ho; G Li
Journal:  Br J Cancer       Date:  2006-06-06       Impact factor: 7.640

Review 10.  Exploiting ING2 Epigenetic Modulation as a Therapeutic Opportunity for Non-Small Cell Lung Cancer.

Authors:  Alice Blondel; Amine Benberghout; Rémy Pedeux; Charles Ricordel
Journal:  Cancers (Basel)       Date:  2019-10-21       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.